Jonathan Moss to Receptors, Opioid, mu
This is a "connection" page, showing publications Jonathan Moss has written about Receptors, Opioid, mu.
Connection Strength
0.746
-
Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer. Ann Oncol. 2016 11; 27(11):2032-2038.
Score: 0.137
-
The mu opioid receptor: A new target for cancer therapy? Cancer. 2015 Aug 15; 121(16):2681-8.
Score: 0.126
-
The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014; 9(3):e91577.
Score: 0.116
-
Overexpression of the µ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology. 2012 Apr; 116(4):857-67.
Score: 0.101
-
The µ-opioid receptor in cancer progression: is there a direct effect? Anesthesiology. 2012 Apr; 116(4):940-5.
Score: 0.101
-
The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg. 2011 Mar; 112(3):558-67.
Score: 0.093
-
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol. 2007 Aug; 37(2):222-31.
Score: 0.072